News Releases

May 29, 2009 – Curaxis entered into a series of agreements with Southridge Business Solutions, LLC of Ridgefield, Connecticut under which Southridge and its affiliates will (1) assist Curaxis in restructuring its balance sheet, (2) manage the process by which Curaxis will engage in a reverse merger with a public corporation to improve Curaxis’ ability to access capital markets and (3) provide Curaxis with a $20 Million Equity Line of Credit that Curaxis may draw down in installments following the merger and registration of the shares issuable under the Equity Line. Terms of the transaction were not announced.

June 12, 2009 – Curaxis entered into an agreement with Canterbury Investment Partners under which Canterbury will assist Curaxis in developing a strategy to raise equity to fund the costs associated with its planned reverse merger and to support Voyager in its dealings with the financial community.

September 14, 2009 – Curaxis entered into an agreement with GroupMark Financial Services Limited to support Curaxis in investor development and related services, including website development.

<<Archives>>

 

 

 

 


Curaxis Pharmaceutical is engaged in the business of developing therapies for the treatment of Alzheimer’s Disease and age related illness.